Scottsdale, Arizona - August 19, 2019 - ZXEREX® Corporation announces IMPAIR-ID™ Marijuana Impairment Screening, a new non-invasive, fast, inexpensive test to detect “impairment.” IMPAIR-ID incorporates technology developed by a team of scientists and engineers from Arizona State University and Barrow Neurological Institute (Dignity Health).
IMPAIR-ID™ utilizes patented technology to analyze voluntary and involuntary eye movements called saccades, and micro-saccades to detect temporary “impairment” associated with the effect of Marijuana on the brain. The technology references a unique bio-signature to identify and classify temporary changes in the brain attributed to THC, the active ingredient of Marijuana. When combined with an employer’s workplace safety program, IMPAIR-ID™ is geared to reduce injuries, absenteeism, and productivity losses while serving as a deterrent. Because IMPAIR-ID™ only takes a few minutes, screening for Marijuana impairment can be done as often as desired, especially for employees in high risk environments.
Currently, the only way employers can insulate their businesses from drug abuse is to perform pre-employment and random drug testing of saliva, urine or hair. The problem with these tests for Marijuana is that they don’t tell if a worker is currently intoxicated or impaired, because the active ingredient (THC) can remain in the body from 3 to 30 days following use. Positive tests in States where Marijuana is legal are forcing employers to rethink traditional drug testing to deal with Marijuana since the presence of Marijuana in a body fluid is not a useful indicator of “impairment.”
Zxerex plans to address the needs of employers to be followed by public safety and consumers, including parents concerned about potential drug use by children.
For further information, go to IMPAIR-ID.COM, or email our IMPAIR-ID™ team at email@example.com or call (480) 518-9905.